N6-Benzyladenosine (Standard)
N6-Benzyladenosine (Standard) (Benzyladenosine (Standard)) is the analytical standard of N6-Benzyladenosine (HY-N7844). This product is intended for research and analytical applications. N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma-.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 4294-16-0
- Formel: C17H19N5O4
- Molecular Weight:357.36
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-N7844
N6-BenzyladenosineAdenosine Receptor Agonist -
HY-B0016
CapecitabineDNA/RNA Synthesis Inhibitor -
HY-B0307
IdoxuridineAntiviral Agent -
HY-118122
FialuridineAntiviral Agent -
HY-B0017
TelbivudineHBV Replication Inhibitor -
HY-A0061
TrifluridineAnti-Cancer Agent/Anti-Viral Agent -
HY-13578
BrivudineCMV Inhibitor -
HY-113139
1-MethylinosineModified Nucleotide -
HY-B0016R
Capecitabine (Standard)DNA/RNA Synthesis Inhibitor -
HY-13859
ClevudineHBV Inhibitor -
HY-W012009
2'-Deoxy-2'-fluorocytidineAnti-CCHFV Inhibitor -
HY-W012311
3′-DeoxythymidineDNA Polymerase Inhibtior
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 4294-16-0
-
Molecular Weight 357.36
-
Formel C17H19N5O4
-
SMILES
O[C@H]1[C@@H](O)[C@H](N2C(N=CN=C3NCC4=CC=CC=C4)=C3N=C2)O[C@@H]1CO
-
Synonyms
Benzyladenosine (Standard)
-
Structure Classification
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[2]. Castiglioni S, et al. N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells. Anticancer Agents Med Chem. 2013 May;13(4):672-8. [Content Brief]
[3]. Mlejnek P. Caspase inhibition and N6-benzyladenosine-induced apoptosis in HL-60 cells. J Cell Biochem. 2001;83(4):678-89. [Content Brief]
[4]. Kim YA, et al. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents. Biochem Pharmacol. 2007 May 15;73(10):1558-72. [Content Brief]
[5]. Grimaldi M, et al. NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity. Bioorg Chem. 2020 May;98:103449. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
N6-Benzyladenosine (Standard) Related Classifications
HY-N7844R Related Classifications
Powered by Bioz
Keywords
- N6-Benzyladenosine (Standard)
- 4294-16-0
- Benzyladenosine (Standard)
- Apoptosis
- Phytohormone
- Adenosine Receptor
- Reference Standards
- FPPS
- Farnesyl pyrophosphate synthase
- mass spectrometry
- anti-tumor
- neoplastic cells
- caspase-3/9
- anti-toxoplasma
- adenosine kinase
- TgAKS3
- glioma
- benzyladenosine hydroxylated
- cytokinin activity
- Inhibitor
- inhibitor
- inhibit